Scripps Health
Avatar

56 y/o Female with a History of Hepatitis C, Cirrhosis, Exertional Dyspnea and PAH: Clinical Examination and Treatment Considerations

By Scripps Health FEATURING Rajeev Mohan, Ajay Srivastava, Thomas Heywood
March 5, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Scripps Health

2021 Updates in Diabetes Management

Fri, Oct 22, 2021
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
19:40
Sonja Bartolome

PAH Treatment Algorithm

18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almo…

Feat. R. DeFronzo
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

Feat. R. DeFronzo
21:07
Gilead

Combination Therapy in Pulmonary Arterial Hypertension

Feat. M. Chakinala, MD, I. Preston, MD
27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhib…

Feat. B. Greenberg
13:48
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

SGLT2 Inhibitors: Not Just for Diabetics Anymore

Feat. R. Lavelle, Pharmd
17:16
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Approaches to Treating Diabetes that Reduce CV Events: How Effective Are D…

Feat. J. Shen
18:00
Scripps Health

New Developments in Treatment of Heart Failure With Low EF and Pulmonary H…

Feat. T. Heywood
12:23
American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Hospital…

Feat. M. Tipton
13:42
George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

20:56
Stanford Medicine

COVID-19 & Diabetes Treatment: Can We Reduce the Risk of Poorer Outcom…

Feat. A. Peters
12:22
James Klinger

Drug Therapies for PAH

10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combinatio…

Feat. G. Umpierrez
15:25
Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

30:55
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Pulmonary Hypertension: My Patient has High PA Pressure on Echo, What Now?

Feat. T. Heywood
11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. Where …

Feat. M. Kittleson
12:47
Northwestern Medicine Cardiovascular Care

15th Annual Heart Failure Holiday Symposium: Highlights and Takeaways

Feat. J. Wilcox, J. Rich, K. Grady, C. Yancy, N. Sweitzer
17:55
Victor Tapson

Managing Challenging Cases in PAH